Contact Us   Having technical issues or questions regarding this product?
Please Contact Us.
BEI Resources currently limits the total number of "Made to Order" items which can be ordered by a registrant to 10 "Made to Order" items per 6 month period. Please check the Availability Status on the items you are ordering and limit orders appropriately.
NR-20347   Influenza A (H1N1) 2009 Monovalent Vaccine
Price: All BEI Resources products are provided
at no cost to registered researchers.
Description: Influenza A (H1N1) 2009 Monovalent Vaccine
Organism: Influenza A virus
Biosafety Level: 1
Availability Status: In Stock
Store at: 2°C to 8°C
Contributor: NIAID/NIH
Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.

Influenza A (H1N1) 2009 (pdm09) Monovalent Vaccine is an inactivated influenza virus vaccine prepared from influenza viruses propagated in embryonated chicken eggs. The virus-containing allantoic fluid was harvested and inactivated with formaldehyde. The virus was concentrated and purified in a linear sucrose density gradient solution using a continuous flow centrifuge. The virus was then chemically disrupted using a non-ionic surfactant, polyethylene glycol p-isooctylphenyl ether (Triton® X-100), producing a "split virus". The split virus was further purified and suspended in sodium phosphate-buffered isotonic sodium chloride solution. Gelatin (0.05%) was added as a stabilizer. Each 0.5 mL dose may contain residual amounts of formaldehyde (≤ 100 µg), Triton® X-100 (≤ 0.02%) and sucrose (≤ 2.0%). Each 0.5 mL dose also contains thimerosal, a mercury derivative, added as a preservative (25 µg mercury).

The hemagglutinin content was standardized according to U.S. Public Health Service requirements. Each 0.5 mL dose contains the recommended 15 µg of hemagglutinin antigen.

Please note that this vaccine preparation is being released for research use only and not for human use. Vaccines produced for the 2009-2010 season are now past their expiration dates.

Each vial contains 5 mL of split-virus vaccine in phosphate-buffered saline containing 0.05% gelatin and thimerosal (25 µg mercury).
Citations: Acknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Influenza A (H1N1) 2009 Monovalent Vaccine, NR-20347."
For a list of permits that may be required for shipping this product and to set the permit information preferences; please select a country from the drop down below.

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.

Return to Top

Notices and Disclaimers

BEI Resources products are intended for laboratory research purposes only. They are not intended for use in humans.

While BEI Resources uses reasonable efforts to include accurate and up-to-date information on this site, BEI Resources makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. BEI Resources does not warrant that such information has been confirmed to be accurate.

Back to My Search